Page last updated: 2024-08-23

etoposide and Granulomatosis, Lipid

etoposide has been researched along with Granulomatosis, Lipid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agostinelli, C; Broccoli, A; Faccioli, L; Pastore Trossello, M; Spinardi, L; Stefoni, V; Zinzani, PL1
Cappelli, C; Foco, M; Mizzoni, F; Noto, C; Toscano, D; Trasimeni, G; Valentini, D1

Reviews

1 review(s) available for etoposide and Granulomatosis, Lipid

ArticleYear
Bilateral orbital Erdheim-Chester disease treated with 12 weekly administrations of VNCOP-B chemotherapy: a case report and a review of literature.
    Rheumatology international, 2012, Volume: 32, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Drug Administration Schedule; Erdheim-Chester Disease; Etoposide; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Mitoxantrone; Prednisone; Treatment Outcome; Vincristine

2012

Other Studies

1 other study(ies) available for etoposide and Granulomatosis, Lipid

ArticleYear
[Erdheim-Chester disease: a non-Langerhans cell histiocytosis. A clinical-case and review of the literature].
    La Clinica terapeutica, 2004, Volume: 155, Issue:5

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Child; Diagnosis, Differential; Drug Therapy, Combination; Erdheim-Chester Disease; Etoposide; Female; Follow-Up Studies; Hormones; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Middle Aged; Phenotype; Prednisone; Radiography; Somatostatin; Time Factors; Treatment Outcome; Vinblastine

2004